Assessment of lower urinary tract symptoms and their impact on quality of life following radiation therapy for bladder cancer
Bladder · 21.02.2025 · 12 (1) · e21200033
DOI: 10.14440/bladder.2024.0046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bladder, online erschienen am 21.02.2025. Verfasst von Josephine Hyldgaard und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Aarhus University Hospital, Aarhus 8200, Denmark. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Radiation therapy is a common treatment modality for muscle-invasive bladder cancer (BC). Unfortunately, approximately 5 – 10% of treated patients suffer from long-term complications, such as radiation cystitis. While radiation cystitis initially causes urinary symptoms, it can progress to chronic late effects over time. This treatment may have significant physical and psychological implications for cancer survivors.
Methods
This prospective, observational multicenter study was conducted in Denmark from 2020 to 2023. Male patients undergoing radiation treatment for BC were included and stratified into two groups based on radiation strategy: 64 Gy/32 fractions versus 36 Gy/6 fractions. Patients completed baseline and follow-up questionnaires assessing lower urinary tract symptoms and quality of life (QoL).
Results
A total of 26 patients were enrolled into the study, with three patients withdrawing consent. Eleven patients were assigned to the 64 Gy/32 fraction group and 12 to the 36 Gy/6 fraction group. At baseline, patients receiving 64 Gy/32 fraction reported a lower impact on QoL, with a median (interquartile range [IQR]) score of 2 (24) compared to 20 (27) in the 36 Gy/6 fraction group. At the 4-month follow-up, the median (IQR) total QoL score was 25 (27) in the 64 Gy 32 fraction group and 6 (14) in the 36 Gy/6 fraction group. At 12 months, the scores were 16 (35) and 3 (3), respectively.
Conclusion
These findings suggest that the total radiation dose has a greater impact on urinary symptoms and QoL than the fractionation strategy. However, due to the low inclusion rate, these findings should be interpreted with caution.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Aarhus University Hospital, Aarhus 8200, Denmark.
Zitieren
APA
Hyldgaard, J., Als, A. B., Ulhøi, B., Jensen, J., & Graugaard-Jensen, C. (2025). Assessment of lower urinary tract symptoms and their impact on quality of life following radiation therapy for bladder cancer. Bladder, 12(1), e21200033. https://doi.org/10.14440/bladder.2024.0046
Vancouver
Hyldgaard J, Als AB, Ulhøi B, Jensen J, Graugaard-Jensen C. Assessment of lower urinary tract symptoms and their impact on quality of life following radiation therapy for bladder cancer. Bladder. 2025;12(1):e21200033. doi:10.14440/bladder.2024.0046
BibTeX
@article{Hyldgaard2025,
author = {Hyldgaard, Josephine and Als, Anne Birgitte and Ulhøi, Benedicte and Jensen, Jørgen and Graugaard-Jensen, Charlotte},
title = {Assessment of lower urinary tract symptoms and their impact on quality of life following radiation therapy for bladder cancer},
journal = {Bladder},
year = {2025},
volume = {12},
number = {1},
pages = {e21200033},
doi = {10.14440/bladder.2024.0046}
}
EUVIMED